Abstract  Description  Claims  Drawing  Search report  Cited references 

CN201580073309   [0005] 
CN201510142069   [0005]  [0211]  [0220]  [0220] 
CN201610932365   [0005] 
CN201580050638   [0006] 
US3817837A   [0034] 
US3850752A   [0034] 
US3939350A   [0034] 
US3996345A   [0034] 
US4277437A   [0034] 
US4275149A   [0034] 
US4366241A   [0034] 
WO2012079000A   [0079]  [0180] 
WO2013126726A   [0079] 
US20120213783A   [0079]  [0180] 
WO2013059593A   [0180] 
WO2006010834A   [0195] 
US5225539A   [0211] 
US5530101A   [0211] 
US5585089A   [0211] 
US5693762A   [0211] 
US6180370B   [0211] 

J. Biochem. Biophys. Methods   [0027] 
Science   [0027] 
Curr. Opin. Immunol.   [0027] 
Immunol. Today   [0027] 
Bio/Technology   [0027] 
Adv. Drug Deliv. Rev.   [0050] 
Cancer Immunol. Immunol.   [0050] 
Cancer Cell   [0050] 
Nat. Rev. Cancer   [0050] 
Curr. Opin Investig. Drugs   [0050] 
Adv. Drug Deliv. Rev.   [0050] 
Molecular Therapy   [0079] 
Molecular Therapy   [0079] 
Blood   [0079] 
Trends Biotechnol.   [0079]  [0180] 
NEnglJMed.   [0079]  [0180] 
J.Hematol Oncol.   [0079] 
Kabat, Sequences of Proteins of Immunological Interest   [0160] 
J. Mol. Biol.   [0160]  [0161] 
Nature   [0160]  [0161] 
Sequences of Proteins of Immunological Interest   [0161] 
Dev. Comparat. Immunol.   [0161]  [0161] 
Fundamental Immunology   [0165] 
Nat Biotechnol   [0165] 
Nature   [0167] 
Science   [0170] 
Proc. Natl. Acad. Sci. USA   [0170] 
The Pharmacology of Monoclonal Antibodies   [0170] 
Proc. Natl. Acad. Sci. USA   [0170] 
Protein Eng   [0170] 
Eur. J. Immunol.   [0170] 
Cancer Res.   [0170] 
J. Mol. Biol.   [0170] 
Cancer Immunol   [0170] 
Nature   [0179] 
Annual Rev Biochem   [0179] 
J. Hematol Oncol.   [0180] 
J. Mol. Biol.   [0197] 
Comput. Appl. Biosci.   [0197] 
J. Mol. Biol.   [0197] 
Biochem.   [0198] 
Protein Eng   [0198] 
Proc. Natl Acad. Set USA   [0198] 
Immunology-A Synthesis   [0199] 
Remington's Pharmaceutical Sciences   [0200] 
Molecular Cloning: A Laboratory Manual   [0210] 
Refined Laboratory Guide for Molecular Biology   [0210] 
Antibody Engineering: Methods and Protocols   [0211] 
B-cell biology and development   [0238] 
The biochemistry and biology of BAFF, APRIL and their receptors   [0238] 
BAFF supports human B cell differentiation in the lymphoid follicles through distinct receptors   [0238] 
B-cell maturation antigen is a promising target for adoptive T-cell therapy of multiple myeloma   [0238] 
B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses   [0238] 
BCMA Is Essential for the Survival of Long-lived Bone Marrow Plasma Cells   [0238] 
BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone   [0238] 
Multiple myeloma   [0238] 
Cancer statistics, 2014   [0238]